Cassava Sciences | PTIE - Aset Lancar

Harga Saham
1.61
Perubahan Harian
-0.05 -3.01%
Bulanan
-12.02%
Tahunan
2.55%
Q2 Perkiraan
1.58




Aset Lancar Perubahan Tanggal
Abbott USD 26B 1.16B 2025-12
Amgen USD 29.06B 1.17B 2025-12
Biogen USD 8.97B 37.5M 2025-12
Cara Therapeutics USD 38.44M 4.69M 2025-09
Cassava Sciences USD 97.71M 11.2M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Geron USD 520.27M 2.07M 2025-12
J&J USD 59.17B 3.55B 2026-03
Merck USD 47.56B 10.49B 2025-09
Novartis USD 30.46B 2.26B 2025-12
Novavax USD 978.28M 3.69M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12